Navigation Links
Cash Technologies Discusses AMEX Listing Requirements
Date:11/8/2007

LOS ANGELES, Nov. 8 /PRNewswire-FirstCall/ -- Cash Technologies, Inc. (Amex: TQ) ("Cash Tech" or the "Company") announced today that the American Stock Exchange (the "Exchange" or "AMEX") notified Cash Tech on November 2, 2007 that Cash Tech does not meet certain of the Exchange's continued listing standards as set forth in part 10 of the AMEX Company Guide (the "Company Guide). Specifically, Cash Tech is not in compliance with Section 1003(a)(i) of the Company Guide with shareholders' equity of less than $2 million and losses from continuing operations and/or net losses in two out of its three most recent years; Section 1003(a)(ii) of the Company Guide with shareholders' equity of less than $4 million and losses from continuing operations and/or net losses in three out of its four most recent years; 1003(a)(iii) of the Company Guide for having shareholders' equity of less than $6 million and losses from continuing operations and/or net losses in its five most recent fiscal years; and Section 1003(a)(iv) of the Company Guide in that it has sustained such losses which are so substantial to its overall operations or its existing financial resources, or its financial condition has become so impaired that it appears questionable, in the opinion of the Exchange, as to whether such company will be able to continue operations and/or meet its obligations as they mature; and Section 301 of the Company Guide in that Cash Tech issued or authorized its transfer agent or registrar to issue or register, additional securities of a listed class prior to receiving notification from the Exchange that the securities have been approved for listing.

In addition, in accordance with Section 610(b) of the Company Guide, a company that receives an audit opinion that contains a going concern qualification must make a public announcement through the news media disclosing the receipt of such qualified opinion. In its Form 10-KSB for the fiscal year ended May 31, 2007, Cash Tech received an audit opinion that contained such a qualification but did not issue such a press release in a timely manner. Accordingly, notice is hereby given of the going concern qualification in the May 31, 2007 audited financial statements.

To maintain its listing, Cash Tech must submit a plan by December 3, 2007 advising the Exchange of actions it has taken, or will take, that would bring Cash Tech into compliance with the continued listing standards above by February 1, 2008. The Exchange will evaluate the plan and make a determination as to whether Cash Tech has made a reasonable demonstration in the plan of an ability to regain compliance with the Continued Listing Standards by February 1, 2008, in which case the plan will be accepted. If the Exchange does not accept the plan or if Cash Tech fails to meet the targets of the plan, the Exchange may initiate delisting procedures. If the plan is accepted, Cash Tech may be able to continue its listing during the plan period, during which time Cash Tech is required to make progress consistent with the plan and to regain compliance with the listing standards.

The Company intends to submit a plan to AMEX that shows Cash Tech's ability to regain compliance with all of the AMEX listing requirements. Specifically, to address liquidity issues the Company has raised $750,000 in new working capital of which $250,000 has funded and the remainder is scheduled to fund on Tuesday, November 13, 2007. Furthermore, the Company has engaged New York investment banking firm HPC Capital Management Corp. to arrange an additional $2,000,000 in working capital. Such financings, if successfully completed, are anticipated to carry the Company to a cash flow breakeven point.

In addition, the Company is pursuing plans to restore its stockholders' equity to meet the AMEX requirements. In particular, the Company is negotiating equity investments in complimentary businesses in the healthcare industry. Also the Company has submitted an offer to acquire the assets of Champion Parts, Inc. through its pending bankruptcy action. The default by Champion of its $9.5 million note to Cash Tech was the primary cause of the reduction of the Company's stockholders' equity. If successful, these actions would, in the opinion of management, bring the Company back into compliance with the AMEX listing standards.

Bruce Korman, Cash Tech's CEO, stated, "We have a successful track record of increasing stockholder equity. In 2005 and 2006 we successfully met targets to increase equity by more than $16 million to regain compliance with AMEX requirements. We are again taking aggressive action to protect our AMEX listing." Korman added, "In addition we are continuing to grow our core business and believe that positive developments in the marketing of our products will begin to generate increased market support and share value."

About Cash Technologies

Cash Technologies, Inc. develops and markets innovative data processing solutions in the healthcare and financial services industries. Its ClaimRemedi Services, Inc. subsidiary creates and markets healthcare revenue acceleration solutions -- learn more at http://www.Claim-Remedi.com. Its CashTechCard Systems, Inc. subsidiary creates and markets stored value card programs. For more information, visit http://www.cashtechcard.com.

Matters discussed in this release include forward-looking statements that involve risks and uncertainties, and actual results may be materially different. Factors that could cause actual results to differ include Cash Technologies' inability to timely submit a plan to AMEX, the rejection of the company's plan by AMEX, the inability of Cash Technologies to raise additional capital, sell some of its assets, or otherwise comply with the initiatives it expects to include in its AMEX plan.

Media Contact:

Ed King

213-745-2000 Ext. 114

eking@cashtech.com


'/>"/>
SOURCE Cash Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
2. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
3. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
4. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
5. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
6. Advanced technologies aim to transform the coaching of top athletes
7. Global Med Technologies(R) Extends Its Worldwide Outreach
8. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
9. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
10. Neurobiological Technologies Reports Going Concern Qualification
11. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... Researchers can ... so routine. A fresh look at this technique may yield big benefits. Scientists ... reproducibility of experiments in a cell culture laboratory—and lessen the risk of contamination ...
(Date:5/23/2016)... ... May 23, 2016 , ... In light of ... reminds pet owners that intervening at the first sign of their pet overheating ... normal body mechanisms cannot keep the body’s temperature within a safe range. Considered ...
(Date:5/23/2016)... ... May 23, 2016 , ... The Society for Women’s Health ... to move on from that role. , “No one in Washington led the way ... said SWHR Founder Florence Haseltine, MD, PhD. “We offer our deep gratitude to Phyllis ...
(Date:5/23/2016)... ... 2016 , ... Hadley Institute for the Blind and Visually ... or visually impaired, announces the election of Julie S. Tye as its next ... of Trustees retained Morris & Berger, a firm specializing in non-profit executive searches, ...
(Date:5/23/2016)... NY (PRWEB) , ... May 23, 2016 , ... ... the company’s top management team to meet the needs of its recent and ... to drive continued growth and business development across widening market segments. Max joined ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 23, 2016 Gamida Cell, a ... of cancer and orphan genetic diseases, announced today it ... million from the Israel Innovation Authority (formerly the Office ... Economy and Industry. The mission of the Israel Innovation ... industries, including science and technology, while stimulating economic growth. ...
(Date:5/22/2016)... 2016 DS Biopharma (DS) ... anti-inflammatory compound DS102 in chronic obstructive pulmonary disease ... (NASH) patients. Recent DS preclinical data ... tissue and has bronchodilatory, anti-inflammatory and anti-fibrotic properties ... Company will publish further detail on these findings ...
(Date:5/20/2016)... 2016 - Revenue Forecasts ... Growth Hormones, Recombinant Coagulation Factors and Regenerative Medicine ... New Study Reveals Selling Opportunities and Revenue Prospects ... ,What is the future of biologics, especially new ... commercial analysis. Staying ahead in data and knowledge, ...
Breaking Medicine Technology: